Attorney Hong also provides legal advisory services for US Flips involving Korean biotech companies. US Flips often hinge on securing consent from existing investors, as their shares must be contributed to the newly established US entity.
While establishing a US entity may seem straightforward, the real challenge lies in structuring the governance of the US entity, aligning shareholder interests, and meticulously drafting shareholder agreements to reflect these arrangements.
Our firm operates seamlessly with a team of US-licensed and Korea-licensed attorneys, enabling real-time collaboration and providing immediate, hands-on support to clients executing US Flips.
